Chronic effects of losartan on the muscles and the serologic profiles of mdx mice

This publication has 24 references indexed in Scilit:

• HDL and atherosclerosis: Insights from inherited HDL disorders
  Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2015
• Chronic Losartan Administration Reduces Mortality and Preserves Cardiac but Not Skeletal Muscle Function in Dystrophic Mice
  PLOS ONE, 2011
• Losartan Restores Skeletal Muscle Remodeling and Protects Against Disuse Atrophy in Sarcopenia
  Science Translational Medicine, 2011
• Role of TGF-β signaling in inherited and acquired myopathies
  Skeletal Muscle, 2011
• Angiotensin II type 1 receptor blockade attenuates TGF-β–induced failure of muscle regeneration in multiple myopathic states
  Nature Medicine, 2007
• Effect of losartan on TGF‐β1 and urinary albumin excretion in patients with type 2 diabetes mellitus and microalbuminuria
  Nephrology Dialysis Transplantation, 2001
• Losartan decreases plasma levels of TGF-β1 in transplant patients with chronic allograft nephropathy
  Kidney International, 1999
• Three muscular dystrophies: Loss of cytoskeleton-extracellular matrix linkage
  Cell, 1995
• Transforming Growth Factor β in Tissue Fibrosis
  New England Journal of Medicine, 1994
• X chromosome-linked muscular dystrophy (mdx) in the mouse.
  Proceedings of the National Academy of Sciences, 1984